Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 2025
- With prize money of one million euros, it is one of the most highly endowed medical awards in the world
- Awarded for groundbreaking pioneering work in cancer therapy using CAR-T cells
- Award Ceremony with Hessian Prime Minister Boris Rhein
A Revolution in Cancer Therapy
Dr. Carl June and Dr. Michel Sadelain are recognized for their pioneering roles in the genetic modification of T-cells, which enable these cells to identify, attack, and destroy cancer cells. They use synthetic receptors, so-called chimeric antigen receptors (CARs), which enable T cells to see and kill cancer cells. CAR-T cells achieve remarkable success rates in cancers such as leukemia, lymphomas, and myelomas; for other cancers, this new approach is still in the experimental phase.
Dr. Carl June, the Richard W. Vague Professor in Immunotherapy at the University of Pennsylvania Perelman School of Medicine, says: "I am deeply honored to receive the inaugural Broermann Medical Innovation Award together with my esteemed colleague Michel Sadelain. This award not only recognizes our decades of research but above all the transformative potential of CAR-T cell therapy for cancer patients worldwide."
Dr. Michel Sadelain, Director of the Columbia Initiative in Cell Engineering and Therapy (CICET), says: "Receiving the Broermann Medical Innovation Award is an extraordinary honor for me and a recognition of the revolutionary power of CAR-T cell therapy. Together with Carl June, we have worked to turn the immune system into a precise weapon against cancer. Our work precisely symbolizes what the Broermann Award stands for: medical breakthroughs that fundamentally change patients’ lives. It fills me with profound gratitude to know that our research helps usher in a new era of cancer treatment and create hope for patients who were once considered incurable."
CAR-T cell therapy has achieved remarkable success rates in treating cancers such as leukemia, lymphoma, and myeloma. Through their visionary research, Sadelain and June have ushered in a completely new era in cancer treatment.
Selection process by the renowned jury
The laureates of the Broermann Medical Innovation Award are selected by an outstanding scientific jury consisting of nine senior members of renowned institutes: Prof. Dr. Werner Seeger (Chair of the Broermann Medical Innovation Award), Prof. Dr. Karsten Krüger (Member of the Executive Board of Justus Liebig University Giessen), Prof. Dr. Isabelle Bekeredjian-Ding (Director Center of Infection, Inflammation and Immunity, University of Marburg), Prof. Dr. Britta Siegmund (Vice President of the German Research Foundation), Prof. Dr. Stefan Offermanns (Director of the Max Planck Institute for Heart and Lung Research), Prof. Dr. Otmar Wiestler (President of the Helmholtz Association), Prof. Dr. Dr. Gerd Geißlinger (Director of the Fraunhofer Institute for Clinical Pharmacology), Prof. Dr. Martina Brockmeier (President of the Leibniz Association), and Dr. Jan Liersch (Managing Director of Broermann Holding GmbH). Supported by a group of international reviewers, the committee evaluates all nominations in a multi-stage process that ensures the highest scientific quality and independence. The decision is based on strict selection criteria.
- Picture is available at AP -
Press contact:
Broermann Medical Innovation Award
Mirjam Malko
Tel.: +49 (0) 641 / 985-42310
E-Mail: contact@broermann-award.org
Asklepios Kliniken
Konzernbereich Unternehmenskommunikation & Marketing
Tel.: +49 (0) 40 / 18 18-82 66 36
E-Mail: presse@asklepios.com
24-hour press office hotline: +49 (0) 40 / 1818-82 8888
Visit Asklepios on the Internet and Social Media:
www.asklepios.com/gesundheitsmagazin
http://www.youtube.com/asklepioskliniken
de.linkedin.com/company/asklepios
Images
About the laureates
Dr. Carl June was born in Denver, USA, in 1953. He received his MD from Baylor College of Medicine in Houston and his postdoctoral training at the Fred Hutchinson Cancer Research Center in Seattle. Following a research career in the US Navy, June founded the Center for Cellular Immunotherapies (CCI) at the University of Pennsylvania in 1999 and established a leading interdisciplinary research initiative for cellular immunotherapies. In 2012, he received the prestigious Richard W. Vague Professorship.
Dr. Michel Sadelain was born in Paris, France, in 1960 and received his medical degree from the University of Paris in 1984 and his PhD from the University of Alberta, Canada in 1989, before conducting postdoctoral research at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology (MIT). In 1994, he joined Memorial Sloan Kettering Cancer Center in New York. Sadelain now serves as director of the Columbia Initiative in Cell Engineering and Therapy (CICET) center in New York, established in 2024, where he leads innovative cell therapy research.
Both scientists have received numerous scientific prizes for their pioneering contributions to cancer therapy.
About the Broermann Medical Innovation Award
The Broermann Medical Innovation Award was established in 2024 by Dr. Bernard große Broermann, namesake and founder of the Asklepios Kliniken Group. Even during his lifetime, Dr. große Broermann was guided by the vision of creating an innovative healthcare company that delivers real value to people. Under his leadership, Asklepios set new standards in medical innovation, making targeted investments in cutting-edge medical technology and digital solutions, thereby advancing patient care — values that also form the foundation of the Broermann Medical Innovation Award. The award carries forward his vision and continues to highlight the commitment of his foundation beyond his lifetime. With a record prize of one million euros, the award is presented in a formal ceremony at the Hessian State Chancellery in Wiesbaden by the current Hessian Prime Minister, Boris Rhein.
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Holistic AI-Driven Cyber Security Platform: Schwarz Digits, XM Cyber and SentinelOne deepen Strategic Alliance18.9.2025 14:33:38 CEST | Press release
Strategic Partnership for a holistic, AI-Powered Security Platform: A product leveraging the capabilities of SentinelOne, XM Cyber, and Omniac creates a 360-degree security solution for companies and the public sector. Forging A Stronger Security Alliance: The integration of SentinelOnes’ SecOps solutions with XM Cyber's leading CTEM creates a powerful security platform. AI's Rapid Adoption Security Strategy: This partnership will mitigate the significant cybersecurity risks associated with AI adoption, to protect organizational assets. Sovereign Protection, already running for the first customer: The new solution is also available on Schwarz Digits' sovereign European cloud STACKIT. It is already in use at Schwarz Group companies.
PLAN-B NET ZERO honoured with the Future Award at Europe’s largest AI festival16.9.2025 10:25:47 CEST | Press release
Berlin – PLAN-B NET ZERO was honoured with the prestigious Future Award in front of 8,500 attendees at Europe’s largest AI festival, the Big Bang Festival. The award jury of the German Institute for Sustainability & Economics recognised the company’s visionary contribution to transforming the energy market and accelerating the energy transition through the integration of artificial intelligence, big data, and renewable energy. The independent jury was particularly impressed by PLAN-B NET ZERO’s ability to combine green energy with artificial intelligence, community-driven approaches, and innovative business models. The concept of transforming traditional electricity customers into active community members—who contribute to sustainable consumption through gamification, CO₂ tracking, and shared challenges—proved especially convincing. “This honour is a powerful signal and a validation of our mission to make energy not only CO2-free, but also smart, data-driven, and a shared experience,”
30 Years of BODY WORLDS15.9.2025 09:43:08 CEST | Press release
A Success Story That Has Changed the Way We See Ourselves
Europe's largest classic and modern classic car market makes history15.9.2025 09:38:00 CEST | Press release
(Ladenburg, Germany) – Veterama celebrates its 50th anniversary in Mannheim: From October 10 to 12, 2025, the Maimarkt grounds in Mannheim will be transformed into an Eldorado for lovers of classic mobility for the 50th time. What began in 1975 as a small exchange market with around 30 dealers, founded by Winfried A. Seidel and Walter Metz, is now a legendary market spectacle with over 4,000 exhibitors from all over Europe. The extensive grounds not only include a huge open space of 260,000 m², but also 15,000 m² of hall space where complete vehicles, spare parts, and accessories are presented. A special focus is on the large vehicle marketplace, where over 500 complete vehicles are on offer. The two- and four-wheelers from all eras and price ranges are sure to make every collector's heart beat faster. In response to customer requests, this year we are offering an early bird ticket, which is valid as a day ticket for Friday, a premium ticket from Friday to Sunday, and day tickets for S
#farewellB757: Condor celebrates the end of an era12.9.2025 12:42:06 CEST | Press release
Germany’s last Boeing 757-300 takes off for a farewell flight on November 5, 2025.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom